M&A Deal Summary |
|
---|---|
Date | 2017-11-14 |
Target | Cardinal Health - China Business |
Sector | Healthcare Services |
Buyer(s) | Shanghai Pharma |
Sellers(s) | Cardinal Health |
Deal Type | Divestiture |
Deal Value | 1.2B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1994 |
Sector | Life Science |
Employees | 49,234 |
Revenue | 260.3B CNY (2023) |
Shanghai Pharma is a pharmaceutical group with business extending across the entire value chain. The company is engaged in the research and development, manufacturing, distribution, and retail of pharmaceutical products and innovative healthcare services. Its revenue and profit sustained growth at CAGR of 15.4% and 11.7% from 2011 to 2016 reaching RMB120.8 billion and RMB3.8 billion respectively. Shanghai Pharma was founded in 1994 and is based in Shanghai, China.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Healthcare Services) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (China) | 1 of 1 |
Year (2017) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
Category | Company |
---|---|
Founded | 1979 |
Sector | Distribution |
Employees | 47,040 |
Revenue | 205.0B USD (2023) |
Cardinal Health is a distributor of healthcare products. Cardinal Health manufactures medical and surgical products and distributes pharmaceuticals and medical supplies worldwide. Cardinal Health was founded in 1979 and is based in Dublin, Ohio.
DEAL STATS | # |
---|---|
Overall | 7 of 10 |
Sector (Healthcare Services) | 2 of 4 |
Type (Divestiture) | 6 of 7 |
Country (China) | 1 of 1 |
Year (2017) | 1 of 1 |
Size (of disclosed) | 2 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-04-18 |
Medtronic - Patient Care Deep Vein Thrombosis & Nutritional Insufficiency Businesses
United States Medtronic - Patient Care, Deep Vein Thrombosis & Nutritional Insufficiency Businesses encompass 23 product categories across multiple market settings, including numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo, which are used in nearly every U.S. hospital. |
Buy | $6.1B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-06-13 |
NaviHealth
Brentwood, Tennessee, United States NaviHealth, Inc. is the largest manager of post-acute benefits for health plans and a leading value-based care partner to health systems and providers. naviHealth currently serves more than two million insured members and manages care transitions for approximately 800 acute hospitals and 11,000 post-acute care facilities nationwide. |
Sell | - |